Comprehensive analysis of mortality among patients undergoing TAVR: Results of the PARTNER trial

Journal of the American College of Cardiology

Volumn 64, Issue 2, 2014, Pages 158-168

  Svensson, Lars G ^a,b,l   Blackstone, Eugene H ^a,b,l   Rajeswaran, Jeevanantham ^a,b,l   Brozzi, Nicholas ^a   Leon, Martin B ^b,c,l   Smith, Craig R ^c   Mack, Michael ^d   Miller, D Craig ^e   Moses, Jeffrey W ^c   Tuzcu, E Murat ^a   Webb, John G ^h   Kapadia, Samir ^a   Fontana, Gregory P ^g   Makkar, Raj R ^g   Brown, David L ^d   Block, Peter C ⁱ   Guyton, Robert A ⁱ   Thourani, Vinod H ⁱ   Pichard, Augusto D ^j   Bavaria, Joseph E ^k   Herrmann, Howard C ^k   Williams, Mathew R ^c   Babaliaros, Vasilis ⁱ   Généreux, Philippe ^c   Akin, Jodi J ^f   more..

^a LERNER RESEARCH INSTITUTE   (United States)

^b PARTNER Publication Office   (United States)

^c Department of Medicine   (United States)

^d BAYLOR HEALTH CARE SYSTEM   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f EDWARDS LIFESCIENCES   (United States)

^g CEDARS SINAI MEDICAL CENTER   (United States)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j WASHINGTON HOSPITAL CENTER   (United States)

^k HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^l PARTNER Publication Office   (United States)

more..

Author keywords

aortic stenosis; causes of death; TAVR

Indexed keywords

AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; BRAIN DISEASE; CARDIOVASCULAR MORTALITY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; HEART ARRHYTHMIA; HEART FAILURE; HIGH RISK PATIENT; HUMAN; INFECTION; INTERMETHOD COMPARISON; INTESTINE NECROSIS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; SUDDEN CARDIAC DEATH; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL RATE; SURVIVAL TIME; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME;

AORTIC STENOSIS; CAUSES OF DEATH; TAVR;

AGED; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84903984160     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.08.1666     Document Type: Article

References (30)

1. J. Ross Jr., and E. Braunwald Aortic stenosis Circulation 38 1968 61 67
2. M.D. Cheitlin, E.W. Gertz, and B.H. Brundage et al. Rate of progression of severity of valvular aortic stenosis in the adult Am Heart J 98 1979 689 700
3. J.G. Webb, L. Altwegg, and R.H. Boone et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes Circulation 119 2009 3009 3016
4. P. Varadarajan, N. Kapoor, and R.C. Bansal et al. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis Ann Thorac Surg 82 2006 2111 2115
5. S.M. O'Brien, D.M. Shahian, and G. Filardo et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2 - isolated valve surgery Ann Thorac Surg 88 2009 S23 S42
6. T.M. Dewey, D. Brown, and W.H. Ryan et al. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement J Thorac Cardiovasc Surg 135 2008 180 187
7. J.G. Webb, M. Chandavimol, and C.R. Thompson et al. Percutaneous aortic valve implantation retrograde from the femoral artery Circulation 113 2006 842 850
8. E. Grube, J.C. Laborde, and U. Gerckens et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study Circulation 114 2006 1616 1624
9. L.G. Svensson, T. Dewey, and S. Kapadia et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex Ann Thorac Surg 86 2008 46 54 discussion 54-5
10. E. Grube, L. Buellesfeld, and R. Mueller et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system Circ Cardiovasc Interv 1 2008 167 175
11. M.B. Leon, C.R. Smith, and M. Mack et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
12. C.R. Smith, M.B. Leon, and M.J. Mack et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
13. S.K. Kodali, M.R. Williams, and C.R. Smith et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement N Engl J Med 366 2012 1686 1695
14. R.R. Makkar, G.P. Fontana, and H. Jilaihawi et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis N Engl J Med 366 2012 1696 1704
15. E.H. Blackstone, D.C. Naftel, and M.E. Turner Jr. The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information J Am Stat Assoc 81 1986 615 624
16. ACC/AHA guidelines and indications for coronary artery bypass graft surgery. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Coronary Artery Bypass Graft Surgery) Circulation 83 1991 1125 1173
17. P.K. Andersen, O. Borgan, and R.D. Gill et al. Nonparametric estimation In: Statistical Models Based on Counting Processes 1993 Springer-Verlag New York, NY
18. E.H. Blackstone Outcome analysis using hazard function methodology Ann Thorac Surg 61 1996 S2 S7 discussion S33-4
19. E.H. Blackstone, and J.W. Kirklin Death and other time-related events after valve replacement Circulation 72 1985 753 767
20. J.M. Beach, T. Mihaljevic, and J. Rajeswaran et al. Ventricular hypertrophy and left atrial dilatation persist and are associated with reduced survival after valve replacement for aortic stenosis J Thorac Cardiovasc Surg 147 2014 362 369.e8
21. A.R. Castaneda, G.A. Trusler, and M.H. Paul et al. The early results of treatment of simple transposition in the current era J Thorac Cardiovasc Surg 95 1988 14 28
22. J.E. Bavaria, W.Y. Szeto, and L.A. Roche et al. The progression of a transcatheter aortic valve program: a decision analysis of more than 680 patient referrals Ann Thorac Surg 92 2011 2072 2076 discussion 2076-7
23. S.R. Kapadia, S.S. Goel, and L. Svensson et al. Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement J Thorac Cardiovasc Surg 137 2009 1430 1435
24. I. Ben-Dor, D. Dvir, and I.M. Barbash et al. Outcomes of patients with severe aortic stenosis at high surgical risk evaluated in a trial of transcatheter aortic valve implantation Am J Cardiol 110 2012 1008 1014
25. M.J. Reardon, and M.R. Reynolds Cost-effectiveness of TAVR in the non-surgical population J Med Econ 16 2013 575 579
26. P. Genereux, J.G. Webb, and L.G. Svensson et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial J Am Coll Cardiol 60 2012 1043 1052
27. D.C. Miller, E.H. Blackstone, and M.J. Mack et al. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial J Thorac Cardiovasc Surg 143 2012 832 843.e13
28. L.G. Svensson Percutaneous aortic valves: effective in inoperable patients, what price in high-risk patients? J Thorac Cardiovasc Surg 140 2010 S10 S13 discussion S86-91
29. H.V. Schaff Transcatheter aortic-valve implantation - at what price? N Engl J Med 364 2011 2256 2258
30. L.G. Svensson, M. Tuzcu, and S. Kapadia et al. A comprehensive review of the PARTNER trial J Thorac Cardiovasc Surg 145 2013 S11 S16